Loading…
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
89pct
97d open
vs 5,674 other S bills in the 119th — cohort avg 32d
Stem Cell Therapeutic and Research Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. The bill also expands periodic reviews of the state of stem cell science to specifically include a review of the use of high-quality cord blood units and other emergent technologies to develop new therapies for potential inclusion in the program. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2026 · third_quarter · Family issues/Abortion/Adoption
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Shield laws Chemical abortion drugs H.R. 7, S. 186 - No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025 SAVE Moms and Babies Act of 2026 Forced Abortion Prevention and Accountability Act Patient Protection and Affordable Care Act H.R.1 - Working Families Tax Cuts Act H.R.6945, S.4242 - Supporting Pregnant and Parenting Women and Families Act H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025 S. 2955; HR 6466 - Forced Abortion Prevention and Accountability Act S.3697, H.R.685 - SAVE Moms and Babies Act of 2026 Patient Protection and Affordable Care Act Abortion funding IVF issues National Defense Authorization Act H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act Presidential Administration Actions S.3264, H.R.6538 More Affordable Care Act H.R.6359 Pregnant Students Rights Act H.R.4876 - Reproductive Freedom for Veterans Act H.R.8084 - Access to LARCs Act H.R.8083 -Allowing Greater Access to Safe and Effective Contraception Act S.4066 - Safeguarding Women from Chemical Abortion Act H.R.7235- Protecting Motherhood Act H.R.7983 - Clean Water for All Life Act H.R.1- Working Families Tax Cuts Act S.2296, H.R.8800 - National Defense Authorization Act H.R.8806 - Supporting Newborn Parents Act of 2026 H.R.9065 - Pregnancy Loss Mental Health Research Act of 2026 H.R.5582, S.2355 - Patients Deserve Price Tags Act H.R.5485 - Second Chance at Life Act H.R.8119- HOPE with Fertility Services Act S.4507, H.R.8784 - Bereaved Parents Rights Act S.4109 - Stem Cell Therapeutic and Research Reauthorization Act of 2026 S.3799, H.R.3302 - Healthy Start Reauthorization Act of 2026 H.R.8239 - SACRED Act S.4880, H.R.8603 - Dismemberment Abortion Ban Act of 2026 S.4873 - Promoting Human Flourishing in Foreign Assistance Act S.253, H.R.73- Abortion Is Not Health Care Act of 2025 H. Res. 11 - Truth in Womens Healthcare Act H.R. 9421 - Ban Abortion By Mail Act H.R. 729 - Teleabortion Prevention Act of 2025 H.R.8495 - Financial Services and General Government Appropriations Act, 2027 S.380 - Rural Obstetrics Readiness Act H.R. 627 - Ensuring Accurate and Complete Abortion Data Reporting Act H.R. 10356 - Empowering Moms Act S.Res. 912/H.Res. 1584 - Recognizing the 50th anniversary of the Hyde Amendment and its enduring legacy of saving the lives of more than 2,600,000 unborn children and respecting the conscience rights of the American people. H.R.10178 - SHIELD Act H.R.6238/S.3254 - NIH IMPROVE Act H.R.12 - Womens Health Protection Act H.R.4611 - Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R.682 - Heartbeat Protection Act of 2025 H.R.589 - FACE Act Repeal Act of 2025 H.R.632 - Protecting Life on College Campus Act of 2025 H.R.1349 - Womens Protection in Telehealth Act H.R.8784 - Bereaved Parents Rights Act H.R.722 - Life at Conception Act H.R.629 - Ending Chemical Abortions Act of 2025
Client expense: $310,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2026 · third_quarter · Health Issues
Shield laws Chemical abortion drugs H.R. 7, S. 186 - No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025 SAVE Moms and Babies Act of 2026 Forced Abortion Prevention and Accountability Act Patient Protection and Affordable Care Act H.R.1 - Working Families Tax Cuts Act H.R.6945, S.4242 - Supporting Pregnant and Parenting Women and Families Act H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025 S. 2955; HR 6466 - Forced Abortion Prevention and Accountability Act S.3697, H.R.685 - SAVE Moms and Babies Act of 2026 Patient Protection and Affordable Care Act Abortion funding IVF issues National Defense Authorization Act H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act Presidential Administration Actions S.3264, H.R.6538 More Affordable Care Act H.R.6359 Pregnant Students Rights Act H.R.4876 - Reproductive Freedom for Veterans Act H.R.8084 - Access to LARCs Act H.R.8083 -Allowing Greater Access to Safe and Effective Contraception Act S.4066 - Safeguarding Women from Chemical Abortion Act H.R.7235- Protecting Motherhood Act H.R.7983 - Clean Water for All Life Act H.R.1- Working Families Tax Cuts Act S.2296, H.R.8800 - National Defense Authorization Act H.R.8806 - Supporting Newborn Parents Act of 2026 H.R.9065 - Pregnancy Loss Mental Health Research Act of 2026 H.R.5582, S.2355 - Patients Deserve Price Tags Act H.R.5485 - Second Chance at Life Act H.R.8119- HOPE with Fertility Services Act S.4507, H.R.8784 - Bereaved Parents Rights Act S.4109 - Stem Cell Therapeutic and Research Reauthorization Act of 2026 S.3799, H.R.3302 - Healthy Start Reauthorization Act of 2026 H.R.8239 - SACRED Act S.4880, H.R.8603 - Dismemberment Abortion Ban Act of 2026 S.4873 - Promoting Human Flourishing in Foreign Assistance Act S.253, H.R.73- Abortion Is Not Health Care Act of 2025 H. Res. 11 - Truth in Womens Healthcare Act H.R. 9421 - Ban Abortion By Mail Act H.R. 729 - Teleabortion Prevention Act of 2025 H.R.8495 - Financial Services and General Government Appropriations Act, 2027 S.380 - Rural Obstetrics Readiness Act H.R. 627 - Ensuring Accurate and Complete Abortion Data Reporting Act H.R. 10356 - Empowering Moms Act S.Res. 912/H.Res. 1584 - Recognizing the 50th anniversary of the Hyde Amendment and its enduring legacy of saving the lives of more than 2,600,000 unborn children and respecting the conscience rights of the American people. H.R.10178 - SHIELD Act H.R.6238/S.3254 - NIH IMPROVE Act H.R.12 - Womens Health Protection Act H.R.4611 - Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R.682 - Heartbeat Protection Act of 2025 H.R.589 - FACE Act Repeal Act of 2025 H.R.632 - Protecting Life on College Campus Act of 2025 H.R.1349 - Womens Protection in Telehealth Act H.R.8784 - Bereaved Parents Rights Act H.R.722 - Life at Conception Act H.R.629 - Ending Chemical Abortions Act of 2025
Client expense: $310,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2026 · third_quarter · Health Issues
Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials.
Client expense: $310,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Issues related to HRSA's regulation of cord blood storage and the Stem Cell Therapeutic and Research Reauthorization Act (H.R. 5160/S. 4109).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
H.R.5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025, Cellular Transplant related issues and initiatives; and Reauthorization related issues S.4109, Stem Cell Therapeutic and Research Reauthorization Act of 2026, Entirety Transplant related issues, generally Monitor the following: Transplant courier issues FDA, Laboratory Developed Tests related issues Public Law 119-21, One Big Beautiful Bill Act, Health care coverage related issues
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medical/Disease Research/Clinical Labs
Higher education; Research and development; and Student loan issues Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Healthcare research and development related issues; and NIH indirect costs H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Healthcare research and development related issues; and NIH indirect costs S.4109, Stem Cell Therapeutic and Research Reauthorization Act of 2026, Entirety
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications OMB Uniform Guidance Oversight H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2026 · second_quarter · Family issues/Abortion/Adoption
Shield laws Chemical abortion drugs H.R.1 - Working Families Tax Cuts Act; H.R.6945, S.4242 - Supporting Pregnant and Parenting Women and Families Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; S. 2955; HR 6466 - Forced Abortion Prevention and Accountability Act; S.3697, H.R.685 - SAVE Moms and Babies Act of 2026; Patient Protection and Affordable Care Act; Abortion funding; IVF issues; National Defense Authorization Act; H.R. 679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; Presidential Administration Actions; S.3264, H.R.6538 More Affordable Care Act; H.R.6359 Pregnant Students Rights Act; H.R.4876 - Reproductive Freedom for Veterans Act H.R.8084 - Access to LARCs Act H.R.8083 -Allowing Greater Access to Safe and Effective Contraception Act S.4066 - Safeguarding Women from Chemical Abortion Act H.R.7235- Protecting Motherhood Act H.R.7983 - Clean Water for All Life Act H.R.8806 - Supporting Newborn Parents Act of 2026 H.R.9065 - Pregnancy Loss Mental Health Research Act of 2026 H.R.5582, S.2355 - Patients Deserve Price Tags Act H.R.5485 - Second Chance at Life Act H.R.8119- HOPE with Fertility Services Act S.4507, H.R.8784 - Bereaved Parents Rights Act S.4109 - Stem Cell Therapeutic and Research Reauthorization Act of 2026 S.3799, H.R.3302 - Healthy Start Reauthorization Act of 2026 H.R.8239 - SACRED Act S.4880, H.R.8603 - Dismemberment Abortion Ban Act of 2026 S.4873 - Promoting Human Flourishing in Foreign Assistance Act S.253, H.R.73- Abortion Is Not Health Care Act of 2025 H. Res. 11 - Truth in Womens Healthcare Act H.R. 9421 - Ban Abortion By Mail Act H.R. 729 - Teleabortion Prevention Act of 2025 H.R.8495 - Financial Services and General Government Appropriations Act, 2027 S.380 - Rural Obstetrics Readiness Act
2026 · second_quarter · Medical/Disease Research/Clinical Labs
Shield laws Chemical abortion drugs H.R.1 - Working Families Tax Cuts Act; H.R.6945, S.4242 - Supporting Pregnant and Parenting Women and Families Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; S. 2955; HR 6466 - Forced Abortion Prevention and Accountability Act; S.3697, H.R.685 - SAVE Moms and Babies Act of 2026; Patient Protection and Affordable Care Act; Abortion funding; IVF issues; National Defense Authorization Act; H.R. 679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; Presidential Administration Actions; S.3264, H.R.6538 More Affordable Care Act; H.R.6359 Pregnant Students Rights Act; H.R.4876 - Reproductive Freedom for Veterans Act H.R.8084 - Access to LARCs Act H.R.8083 -Allowing Greater Access to Safe and Effective Contraception Act S.4066 - Safeguarding Women from Chemical Abortion Act H.R.7235- Protecting Motherhood Act H.R.7983 - Clean Water for All Life Act H.R.8806 - Supporting Newborn Parents Act of 2026 H.R.9065 - Pregnancy Loss Mental Health Research Act of 2026 H.R.5582, S.2355 - Patients Deserve Price Tags Act H.R.5485 - Second Chance at Life Act H.R.8119- HOPE with Fertility Services Act S.4507, H.R.8784 - Bereaved Parents Rights Act S.4109 - Stem Cell Therapeutic and Research Reauthorization Act of 2026 S.3799, H.R.3302 - Healthy Start Reauthorization Act of 2026 H.R.8239 - SACRED Act S.4880, H.R.8603 - Dismemberment Abortion Ban Act of 2026 S.4873 - Promoting Human Flourishing in Foreign Assistance Act S.253, H.R.73- Abortion Is Not Health Care Act of 2025 H. Res. 11 - Truth in Womens Healthcare Act H.R. 9421 - Ban Abortion By Mail Act H.R. 729 - Teleabortion Prevention Act of 2025 H.R.8495 - Financial Services and General Government Appropriations Act, 2027 S.380 - Rural Obstetrics Readiness Act
2026 · second_quarter · Budget/Appropriations
H.R. 7, S. 186 - No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025 Patient Protection and Affordable Care Act Abortion funding S.3264, H.R.6538 - More Affordable Care Act H.R.7148 - Consolidated Appropriations Act, 2026 H.R.6938 - Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriation Act, 2026 H.R.1 - Working Families Tax Cuts Act S.4109- Stem Cell Therapeutic and Research Reauthorization Act of 2026 S.3799, H.R.3302 - Healthy Start Reauthorization Act of 2026 S.4873 - Promoting Human Flourishing in Foreign Assistance Act H.R.8495 - Financial Services and General Government Appropriations Act, 2027
Client expense: $420,000 · Firm income: Not reported
2026 · second_quarter · Health Issues
Shield laws Chemical abortion drugs H.R.1 - Working Families Tax Cuts Act; H.R.6945, S.4242 - Supporting Pregnant and Parenting Women and Families Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; S. 2955; HR 6466 - Forced Abortion Prevention and Accountability Act; S.3697, H.R.685 - SAVE Moms and Babies Act of 2026; Patient Protection and Affordable Care Act; Abortion funding; IVF issues; National Defense Authorization Act; H.R. 679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; H.R. 627 Ensuring Accurate & Complete Abortion Data Reporting Act; H.R. 6466 Forced Abortion Prevention and Accountability Act; Presidential Administration Actions; S.3264, H.R.6538 More Affordable Care Act; H.R.6359 Pregnant Students Rights Act; H.R.4876 - Reproductive Freedom for Veterans Act H.R.8084 - Access to LARCs Act H.R.8083 -Allowing Greater Access to Safe and Effective Contraception Act S.4066 - Safeguarding Women from Chemical Abortion Act H.R.7235- Protecting Motherhood Act H.R.7983 - Clean Water for All Life Act H.R.8806 - Supporting Newborn Parents Act of 2026 H.R.9065 - Pregnancy Loss Mental Health Research Act of 2026 H.R.5582, S.2355 - Patients Deserve Price Tags Act H.R.5485 - Second Chance at Life Act H.R.8119- HOPE with Fertility Services Act S.4507, H.R.8784 - Bereaved Parents Rights Act S.4109 - Stem Cell Therapeutic and Research Reauthorization Act of 2026 S.3799, H.R.3302 - Healthy Start Reauthorization Act of 2026 H.R.8239 - SACRED Act S.4880, H.R.8603 - Dismemberment Abortion Ban Act of 2026 S.4873 - Promoting Human Flourishing in Foreign Assistance Act S.253, H.R.73- Abortion Is Not Health Care Act of 2025 H. Res. 11 - Truth in Womens Healthcare Act H.R. 9421 - Ban Abortion By Mail Act H.R. 729 - Teleabortion Prevention Act of 2025 H.R.8495 - Financial Services and General Government Appropriations Act, 2027 S.380 - Rural Obstetrics Readiness Act
2026 · second_quarter · Health Issues
Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109.
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Issues related to HRSA's regulation of cord blood storage and the Stem Cell Therapeutic and Research Reauthorization Act (HR5160/S4109).
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2026 · second_quarter · Health Issues
Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act S. 4440/H.R. 3521 - The Clinical Trial Modernization Act
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2026 · second_quarter · Health Issues
H.R.5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025, Cellular Transplant related issues and initiatives; and Reauthorization related issues S.4109, Stem Cell Therapeutic and Research Reauthorization Act of 2026, Entirety Transplant related issues, generally Monitor the following: Transplant courier issues FDA, Laboratory Developed Tests related issues Public Law 119-21, One Big Beautiful Bill Act, Health care coverage related issues
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2026 · second_quarter · Medical/Disease Research/Clinical Labs
Higher education; Research and development; and Student loan issues Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Healthcare research and development related issues; and NIH indirect costs H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Healthcare research and development related issues; and NIH indirect costs S.4109, Stem Cell Therapeutic and Research Reauthorization Act of 2026, Entirety
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.
Client expense: $320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2026 · first_quarter · Health Issues
H.R.5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025, Cellular Transplant related issues and initiatives; and Reauthorization related issues S.4109, Stem Cell Therapeutic and Research Reauthorization Act of 2026, Entirety Monitor the following: Transplant courier issues FDA, Laboratory Developed Tests related issues Public Law 119-21, One Big Beautiful Bill Act, Health care coverage related issues
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Stem Cell Therapeutic and Research Reauthorization Act (SCTRRA) (S. 4109/H.R. 5160)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office